A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer

Laura Graham, Kalyan Banda, Alba Torres, Brett S. Carver, Yu Chen, Katie Pisano, Greg Shelkey, Tracy Curley, Howard I. Scher, Tamara L. Lotan, Andrew C. Hsieh, Dana E. Rathkopf

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences